> After opening a new plant in Florida, Xcelience is looking to boost its EU trial supply business. Article
> DSM Pharmaceutical has inked a deal with Paranta Biosciences for process development and cGMP manufacture of Follistatin, the company's lead recombinant human protein. News
> Althea Technologies has won a contract to manufacture a circumsporozoite protein for Pfenex's malaria vaccine. Story
> Penn Pharma recently completed a new solid oral dose facility, and the company says it's in talks with Big Pharma on potential partnerships. More
> AMRI has extended its extended its supply agreement with Shire ($SHPG) for another 5 years. Item